Skip to main content
. 2019 Jun 28;8(3):383–396. doi: 10.1007/s40121-019-0251-4

Fig. 2.

Fig. 2

Observed versus Bayesian posterior individual predicted concentrations for a patient 4 and b patient 15, who received meropenem in the CARE Study. While precision was reasonable for patient 4, individual Bayesian parameter estimates for patient 15 resulted in predicted concentrations significantly different from observed